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ABSTRACT We report here the draft genome sequences of two multidrug-resistant
Acinetobacter baumannii clinical strains, H31499 and H31506, which were isolated at
the Lausanne University Hospital in 2015 from an Albanian and a Togolese patient,
respectively.
Acinetobacter baumannii is an important opportunistic pathogen that causes a widerange of nosocomial infections, including urinary tract, respiratory tract, and blood-
stream infections (1, 2). In recent years, wide dissemination and hospital outbreaks of
multidrug-resistant A. baumannii strains have been reported (3–5). Here, we report the
draft genome sequences of two carbapenemase-producing A. baumannii strains,
H31499 and H31506. Strain H31499 was isolated from an Albanian patient with infected
burn wound, while strain H31506 was retrieved from a Togolese child with an infected
surgical wound. Both of these patients were admitted at the Lausanne University
Hospital in 2015.
The genomic DNA of both strains was extracted using the Wizard genomic DNA
puriﬁcation kit (Promega, Madison, WI, USA), according to the manufacturer’s instruc-
tions. Quantiﬁcation of the extracted genomic DNA was performed using the Qubit
double-stranded DNA high-sensitivity (HS) assay kit (Life Technologies, Inc., Waltham,
MA, USA). Sequencing libraries were prepared using the Nextera XT DNA library
preparation kit (Illumina, San Diego, CA, USA), according to the manufacturer’s guide-
lines, followed by sequencing using the version 2 chemistry protocol on the Illumina
MiSeq platform (Illumina), generating 2  150-bp paired-end reads.
Multilocus sequence typing (MLST) and antimicrobial resistance gene proﬁling were
performed in silico using SRST2 (6). Sequence reads were preprocessed and de novo
assembled using the A5-miseq pipeline (7), with default parameters. Subsequently,
annotations of the assembled draft genomes were performed using RAST (8).
The draft genome sequence of H31499 had 128 contigs that comprised 3,933,485 bp,
with an N50 contig size of 125,943 bp and a GC content of 38.8%. Similarly, the H31506
draft genome sequence consisted of 225 contigs, with an N50 contig size of 50,932 bp that
made up a total length of 4,065,883 bp, with a GC content of 39%.
In silico MLST analysis using the Pasteur Institute typing scheme (9) revealed that
strains H31499 and H31506 belong to sequence type 2 (ST2) and ST575, respectively,
while in the Oxford MLST scheme (10), they belong to ST436 and ST1051, respectively.
SRST2 analysis revealed that the genomes of strains H31499 and H31506 harbored
14 and 12 antimicrobial resistance genes, respectively. Genes that encode resistance to
-lactams (blaOxa-23, blaOXA-51, blaMBL, and ampC), amikacin (aphA6), tetracyclines (tetB),
and sulfonamides (sul2) were detected in both genomes. In addition, the H31498
Received 2 February 2017 Accepted 28
March 2017 Published 18 May 2017
Citation Abdelbary MMH, Prod’hom G, Greub
G, Senn L, Blanc DS. 2017. Draft genome
sequences of two carbapenemase-producing
Acinetobacter baumannii clinical strains isolated
from Albanian and Togolese patients. Genome
Announc 5:e00115-17. https://doi.org/10.1128/
genomeA.00115-17.
Copyright © 2017 Abdelbary et al. This is an
open-access article distributed under the terms
of the Creative Commons Attribution 4.0
International license.
Address correspondence to Dominique S.
Blanc, dominique.blanc@chuv.ch.
PROKARYOTES
crossm
Volume 5 Issue 20 e00115-17 genomea.asm.org 1
 o
n
 June 2, 2017 by BIBLIO
THEQUE DU CHUV
http://genom
ea.asm
.org/
D
ow
nloaded from
 
genome harbored the genes blaTEM-1, armA, aph(3=)-Ia, strA, and strB, while the genes
blaCARB-2, blaPER-1, aadB, and sul1 were unique to the H31506 genome.
Accession number(s). The draft genome sequences of strains H31499 and H31506
have been deposited in the European Nucleotide Archive (ENA)/GenBank under Bio-
Project PRJEB19200 and with accession numbers FTRW00000000 and FTRX00000000,
respectively. The versions described in this paper are the ﬁrst versions.
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